Anti-LATS1/WARTS ((phospho T1079) +LATS2 (phospho T1041) antibody
3
(1 Review)
|
(24 Publications)
Rabbit Polyclonal LATS2 antibody. Suitable for IHC-P and reacts with Human samples. Cited in 24 publications. Immunogen corresponding to Synthetic Peptide within Human LATS1 phospho T1079.
View Alternative Names
KPM, LATS2, Serine/threonine-protein kinase LATS2, Kinase phosphorylated during mitosis protein, Large tumor suppressor homolog 2, Serine/threonine-protein kinase kpm, Warts-like kinase
- IHC-P
Unknown
Immunohistochemistry (Formalin/PFA-fixed paraffin-embedded sections) - Anti-LATS1/WARTS ((phospho T1079) +LATS2 (phospho T1041) antibody (AB111344)
ab111344 at 1/50 dilution staining LATS1 +LATS2 in paraffin-embedded Human Brain tissue by Immunohistochemistry. The image on the right is treated with the synthesized phosphopeptide.
Reactivity data
Properties and storage information
Form
Purification technique
Purification notes
Storage buffer
Shipped at conditions
Appropriate short-term storage conditions
Appropriate long-term storage conditions
Storage information
Supplementary information
This supplementary information is collated from multiple sources and compiled automatically.
Biological function summary
LATS1 and LATS2 are part of the core Hippo signaling complex playing roles in controlling cell growth and organ size. They achieve this by inhibiting the transcription co-activator YAP/TAZ preventing excessive cell division and promoting programmed cell death when needed. This regulation ensures proper development and suppresses tumor formation. LATS proteins act as tumor suppressors preventing the overgrowth of cells that could lead to cancerous transformations.
Pathways
LATS1 and LATS2 integrate into the Hippo signaling and apoptotic pathways. In the Hippo pathway these kinases partner with MOB1 to phosphorylate YAP/TAZ preventing their translocation into the nucleus where they might trigger oncogenic gene expression. They also interact with other proteins like MST1/2 kinases within the Hippo cascade ensuring tight regulation of cell proliferation and death.
Product protocols
- Visit the General protocols
- Visit the Troubleshooting
Target data
Additional targets
Publications (24)
Recent publications for all applications. Explore the full list and refine your search
Biomedicines 11: PubMed37509515
2023
Applications
Unspecified application
Species
Unspecified reactive species
Oncology letters 26:331 PubMed37415630
2023
Applications
Unspecified application
Species
Unspecified reactive species
Oncology research 29:159-174 PubMed37304674
2023
Applications
Unspecified application
Species
Unspecified reactive species
JCI insight 8: PubMed36853804
2023
Applications
Unspecified application
Species
Unspecified reactive species
Journal of Cancer 14:393-402 PubMed36860929
2023
Applications
Unspecified application
Species
Unspecified reactive species
Cancer science 113:2753-2762 PubMed35722967
2022
Applications
Unspecified application
Species
Unspecified reactive species
Open medicine (Warsaw, Poland) 17:453-462 PubMed35350839
2022
Applications
Unspecified application
Species
Unspecified reactive species
Open life sciences 16:1130-1140 PubMed34746414
2021
Applications
Unspecified application
Species
Unspecified reactive species
Molecular medicine reports 24: PubMed34505633
2021
Applications
Unspecified application
Species
Unspecified reactive species
Cell death and differentiation 29:206-217 PubMed34465890
2021
Applications
Unspecified application
Species
Unspecified reactive species
Product promise
Please note: All products are 'FOR RESEARCH USE ONLY. NOT FOR USE IN DIAGNOSTIC OR THERAPEUTIC PROCEDURES'.
For licensing inquiries, please contact partnerships@abcam.com